Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,098,708 papers from all fields of science
Search
Sign In
Create Free Account
PS519
Known as:
MLN-519
, PS 519
, PS-519
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Acetylcysteine
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
CYTOTOXC AGENTS AND METHODS OF USE
P. Ward
2017
Corpus ID: 102335449
Seemuller, et al. “Proteasome from Thermoplasma acidophilum: A Threonine Protease” Science 268:579-582 (1995). Fenteany, et al…
Expand
2011
2011
Proteasome Inhibitor Reduces Astrocytic iNOS Expression and Functional Deficit after Experimental Intracerebral Hemorrhage in Rats
Fahmi M. Al-Senani
,
Xiurong Zhao
,
J. Grotta
,
A. Shirzadi
,
R. Strong
,
J. Aronowski
Translational Stroke Research
2011
Corpus ID: 255963142
Intracerebral hemorrhage (ICH) is associated with perihematoma inflammation and edema. We have recently shown cell death and a…
Expand
Review
2007
Review
2007
The ubiquitin-proteasome system and proteasome inhibitors in central nervous system diseases.
I. Shah
,
M. Di Napoli
Cardiovascular & Haematological Disorders - Drug…
2007
Corpus ID: 22801869
The ubiquitin-proteasome system (UPS) displays an important cellular quality control function, by removing abnormal proteins from…
Expand
2006
2006
Proteasome inhibition attenuates infarct size and preserves cardiac function in a murine model of myocardial ischemia-reperfusion injury
W. Stansfield
,
A. Bhardwaj
,
M. Rojas
,
Ruhang Tang
,
S. Smyth
,
C. Selzman
2006
Corpus ID: 73282328
Review
2004
Review
2004
[The ubiquitin system for intracellular protein degradation--involvement in human pathologies and therapeutic implications].
E. Reinstein
Harefuah
2004
Corpus ID: 6594171
The ubiquitin-proteasome pathway has a central role in selective degradation of intracellular proteins. Among the key proteins…
Expand
Review
2003
Review
2003
MLN-519. Millennium/PAION.
M. Di Napoli
,
F. Papa
Current opinion in investigational drugs
2003
Corpus ID: 28336790
Millennium Pharmaceuticals Inc (formerly LeukoSite Inc) and PAION GmbH are developing MLN-519, a ubiquitin/proteasome enzyme…
Expand
2001
2001
Effects of PS-519 combined with thrombolytic therapy in embolic stroke in rat
Li Zhang
,
Zhenggang Zhang
,
M. Chopp
,
P. Elliott
,
J. Adams
2001
Corpus ID: 79558034
P67 We evaluated the effect of a proteasome inhibitor (PS-519) which blocks the activation of NF-kB, alone or combination with…
Expand
2000
2000
Proteasome Inhibitor PS 519 Reduces Infarction and Attenuates Leukocyte Infiltration in a Rat Model of Focal Cerebral Ischemia
J. Phillips
,
A. Williams
,
J. Adams
,
P. Elliott
,
F. Tortella
2000
Corpus ID: 25937549
Background and Purpose —Reperfusion brain injury after cerebral ischemia is associated with a developing inflammatory response at…
Expand
2000
2000
The proteasome inhibitor PS-519 reduces infarction and significantly improves neurological function
2000
Corpus ID: 195127455
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE